Abstract
5549 Background: The optimal duration of systemic treatment to maximise survival and quality of life (QOL) in ovarian cancer following surgery or in the recurrent setting is unclear. In addition ma...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
